000			06092nam a22004813i 4500
001			EBC3018893
003			MiAaPQ
005			20240729124108.0
006			m o d |
007			cr cnu||||||||
008			240724s2010 xx o ||||0 eng d
020			_a9781611223323 _q(electronic bk.)
020			_z9781616682507
035			_a(MiAaPQ)EBC3018893
035			_a(Au-PeEL)EBL3018893
035			_a(CaPaEBR)ebr10661832
035			_a(OCoLC)669502722
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRC148 -- .R355 2010eb
082	0		_a616.9/53
100	1		_aWilliamson, John G.
245	1	0	_aRabies : _bSymptoms, Treatment and Prevention.
250			_a1st ed.
264		1	_aHauppauge : _bNova Science Publishers, Incorporated, _c2010.
264		4	_c©2010.
300			_a1 online resource (169 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aVirology Research Progress
505	0		_aIntro -- RABIES: SYMPTOMS, TREATMENT AND PREVENTION -- RABIES: SYMPTOMS, TREATMENT AND PREVENTION -- CONTENTS -- PREFACE -- Chapter 1 RABIES PREVENTION: CURRENT TRENDS IN ANTI-RABIES VACCINES -- ABSTRACT -- INTRODUCTION TO RABIES -- THE RABIES VIRUS, GENERAL STRUCTURE -- RABIES VIRUS GLYCOPROTEIN, RVGP, AND IMPLICATION IN DISEASE -- RABIES SYMPTOMS, DIAGNOSIS AND PREVENTION -- TRENDS IN RABIES VACCINES AND POST-EXPOSURE TREATMENT -- Initial Rabies Vaccines -- HDCC Vaccines -- PCEC Vaccines -- Vero-cell Derived Vaccines -- Towards Better Vaccines -- Current Rabies Situation -- NEW TECHNOLOGIES IN RABIES VACCINE THERAPIES -- DNA-BASED VACCINATION APPROACHES -- Plasmid DNA Vaccines -- Pseudorabies DNA Viral Vaccines -- Poxvirus DNA Vaccines -- Adenovirus DNA Vaccines -- Limitations of DNA Vaccines -- Alternative Vaccine Approaches -- DEVELOPMENT OF ALPHAVIRAL-BASED ANTI-RABIES VACCINATIONS -- Alphaviruses and Clinical Applications -- Alphaviruses in Vaccine Therapies -- Alphaviruses in Rabies Vaccination -- OVERVIEW AND CONCLUSION -- REFERENCES -- Chapter 2 RABIES: EPIDEMIOLOGY, PATHOGENESIS, AND PROPHYLAXIS+ -- ABSTRACT -- INTRODUCTION -- EPIDEMIOLOGY -- VIROLOGY -- PATHOGENESIS -- CLINICAL MANIFESTATIONS -- DIFFERENTIAL DIAGNOSIS -- LABORATORY DIAGNOSIS -- TREATMENT -- PREVENTION -- Control of Rabies -- Preexposure Prophylaxis -- Post-Exposure Prophylaxis -- CONCLUSION -- REFERENCES -- Chapter 3 RABIES VIRUS EVASION OF THE INTERFERON SYSTEM -- ABSTRACT -- INTRODUCTION -- THE TYPE I IFN SYSTEM: KEY PLAYER IN RABIES ANTIVIRAL IMMUNITY -- RECOGNITION OF RABIES VIRUS PAMPS AND IFN INDUCTION BY RECEPTORS OF THE INNATE IMMUNE SYSTEM -- RABIES VIRUS COUNTERMEASURES TO THE IFN SYSTEM -- Rabies Virus Phosphoprotein P Inhibits IFN Induction. -- Rabies Virus Phosphoprotein P Inhibits IFN Signaling and ISG Expression.
505	8		_aREVERSE GENETICS TO GENERATE IFN COMPROMISED RABIES VIRUSES -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- Chapter 4 ADVANCES IN RABIES LABORATORY DIAGNOSIS IN BRAZIL -- INTRODUCTION -- EPIDEMIOLOGICAL SITUATION OF RABIES -- RABIES DIAGNOSTIC IN BATS -- FLUORESCENT ANTIBODIES FOR RABIES -- MONOCLONAL ANTIBODIES FOR RABIES -- MOLECULAR BIOLOGY OF THE RABIES VIRUS -- IMMUNOHYSTOCHEMISTRY IN THE DIAGNOSTIC OF RABIES -- ANTE-MORTEM LABORATORY DIAGNOSTIC -- REFERENCES -- Chapter 5 ANTIBODY SEROPREVALENCE AGAINST RABIES OF FREE-ROAMING DOGS IN BOLIVIA -- ABSTRACT -- INTRODUCTION -- Rabies in Bolivia -- Rabies Control Measures in Santa Cruz de la Sierra -- Research on canine rabies in Santa Cruz de la Sierra -- MATERIALS AND METHODS -- Study Area -- Study Animals -- Serum Collection and Laboratory Analysis -- Data Analysis and Mathematical Model -- RESULTS -- DISCUSSION -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- REVIEWED BY -- Chapter 6 LYSSAVIRUS GENOME -- ABSTRACT -- 1. INTRODUCTION -- 2. METHODS FOR SEQUENCING LYSSAVIRUS FULL GENOME -- 2.1. Direct RT-PCR Method -- 2. 2. Rapid Amplification of Cdna Ends (RACE) -- 2.3. Circularization of Viral Genomic RNA -- 3. LYSSAVIRUS GENOME ORGANIZATION -- 3.1. Non-Coding Regions -- 3.1.1.cis- and Trans-Acting Elements -- 3.1.1.1. Leader region (Le) -- 3.1.1.2. Trailer Region (Tr) -- 3.1.1.3. Gene start, transcription termination-polyadenylation (TTP), and intergenic sequences (IGS) -- 3.1.2. M-3' non-translated region -- 3.1.3. G-L 3' non-translated region (Ψ) -- 3.2. CODING REGIONS -- Nucleoprotein (N) -- Phosphoprotein (P) -- Matrix Protein (M) -- Glycoprotein (G) -- RNA Dependent RNA Polymerase (Rdrp or L) -- 4. GENOTYPES IN LYSSAVIRUS -- 4.1. Update -- 4.2. Ancestor -- 5. STRUCTURAL AND FUNCTIONAL CONSTRAINTS VERSUS EVOLUTIONARY TRENDS ON LYSSAVIRUS GENOME.
505	8		_a5.1. Structural and Functional Constraints by Potential Protein Covariations -- 5.1.1. Covariations of the N Protein -- 5.1.2. Covariations Within and Among Viral Structural Proteins -- 5.1.3. Covariations of the R333 residue in the G protein -- 5.2. Evolutionary Driving Forces on Viral Structural Protein Genes -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- DISCLAIMER -- Chapter 7 RABIES AND FREE RADICAL: A RELATIONSHIP -- ABSTRACT -- INTRODUCTION -- FREE RADICAL IN ENCEPHALITIS: WHAT IS ITS ORIGIN? -- PUBLICATION ON RABIES AND FREE RADICAL -- BORNA DISEASE: ANOTHER ENCEPHALITIS VIRUS INFECTION RELATING TO FREE RADICAL -- REFERENCES -- INDEX.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aRabies.
650		0	_aVirology.
655		4	_aElectronic books.
776	0	8	_iPrint version: _aWilliamson, John G. _tRabies: Symptoms, Treatment and Prevention _dHauppauge : Nova Science Publishers, Incorporated,c2010 _z9781616682507
797	2		_aProQuest (Firm)
830		0	_aVirology Research Progress
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018893 _zClick to View
999			_c59932 _d59932